Nuvalent (NUVL) officer Benjamin Lane details stock, options and RSUs in Form 3
Rhea-AI Filing Summary
Nuvalent, Inc. officer Benjamin Lane filed an initial ownership report, listing his equity stake in the company. He directly holds 40,868 shares of Class A Common Stock, along with multiple stock options and restricted stock units that may convert into additional shares over time.
The filing shows stock options over 731, 8,333, 17,848, 15,052, 12,025 and 8,000 shares of Class A Common Stock, with exercise prices from $14.40 to $106.82 and expirations between 2032 and 2036. Footnotes also describe RSUs covering 6,733, 5,200 and 8,000 shares that vest in installments, subject to continued service. The Form 3 reflects holdings rather than new buy or sell transactions.
Positive
- None.
Negative
- None.
Insights
Form 3 shows Lane’s existing Nuvalent equity, no new trades.
The filing details Benjamin Lane’s baseline ownership in Nuvalent, Inc., combining common shares, stock options and RSUs. This is an initial beneficial-ownership snapshot, not a record of fresh market purchases or sales.
Lane holds 40,868 shares of Class A Common Stock plus several option grants with exercise prices from $14.40 to $106.82 and expirations through 2036. Footnotes describe RSUs granted in 2024, 2025 and 2026 that vest over time if service continues.
Because no open-market buy or sell codes appear and transaction counts for purchases and sales are zero, this information is administratively important but not thesis-changing. Future company filings may update these holdings as options vest, RSUs settle, or any actual trades occur.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Class A Common Stock | -- | -- | -- |
Footnotes (1)
- Includes (i) 6,733 shares of Nuvalent, Inc. Class A Common Stock issuable under restricted stock units ("RSUs") granted on January 5, 2024, (ii) 5,200 shares of Nuvalent, Inc. Class A Common Stock issuable under RSUs granted on January 6, 2025, and (iii) 8,000 shares of Nuvalent, Inc. Class A Common Stock issuable under RSUs granted on January 7, 2026. Each RSU represents the right to receive one share of Nuvalent, Inc. Class A Common Stock. The RSUs vest in three equal annual installments following the applicable grant date, subject to continued service to Nuvalent, Inc. through the applicable vesting date. The shares underlying this option are fully vested. The shares underlying this option vest as follows: 25% of the 50,000 shares originally underlying the option vested on August 1, 2023 and the remainder have vested or shall vest over the three years thereafter in equal monthly installments, subject to continued service to Nuvalent, Inc. through the applicable vesting date. The 65,900 shares originally underlying this option have vested or shall vest over the four years following January 6, 2023 in equal monthly installments, subject to continued service to Nuvalent, Inc. through the applicable vesting date. The 28,900 shares originally underlying this option have vested or shall vest over the four years following January 5, 2024 in equal monthly installments, subject to continued service to Nuvalent, Inc. through the applicable vesting date. The 15,600 shares originally underlying this option have vested or shall vest over the four years following January 6, 2025 in equal monthly installments, subject to continued service to Nuvalent, Inc. through the applicable vesting date. The shares underlying this option have vested or shall vest over the four years following January 7, 2026 in equal monthly installments, subject to continued service to Nuvalent, Inc. through the applicable vesting date.
